The global Antiviral Drug Packaging market was valued at US$ 26500 million in 2023 and is anticipated to reach US$ 34130 million by 2030, witnessing a CAGR of 3.7% during the forecast period 2024-2030.

Antiviral Drug Packaging Market

Antiviral drug packaging is specially designed for packaging antiviral drugs. Antiviral drugs are a class of medication used specifically for treating viral infections such as influenza, herpes virus infections, viral hepatitis and human immunodeficiency virus.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Antiviral Drug Packaging, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiviral Drug Packaging.

Report Scope

The Antiviral Drug Packaging market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antiviral Drug Packaging market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antiviral Drug Packaging manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Antiviral Drug Packaging Market Report

Report Metric	Details
Report Name	Antiviral Drug Packaging Market
Accounted market size in 2023	US$ 26500 million
Forecasted market size in 2030	US$ 34130 million
CAGR	3.7%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Rigid Plastic Flexible Blister Foils Others
Segment by Application	Pharmaceuticals Healthcare
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Avery Dennison Corporation, E.I. du Pont de Nemours, CCL Industries Inc, BioCote, Avient, Mondi, Biomaster, BASF, Lonza, Takex Labo Co. Ltd, Berry, Lageen Tubes.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antiviral Drug Packaging manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antiviral Drug Packaging in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Antiviral Drug Packaging Market growing?

Ans: The Antiviral Drug Packaging Market witnessing a CAGR of 3.7% during the forecast period 2024-2030.

What is the Antiviral Drug Packaging Market size in 2030?

Ans: The Antiviral Drug Packaging Market size in 2030 will be US$ 34130 million.

Who are the main players in the Antiviral Drug Packaging Market report?

Ans: The main players in the Antiviral Drug Packaging Market are Avery Dennison Corporation, E.I. du Pont de Nemours, CCL Industries Inc, BioCote, Avient, Mondi, Biomaster, BASF, Lonza, Takex Labo Co. Ltd, Berry, Lageen Tubes.

What are the Application segmentation covered in the Antiviral Drug Packaging Market report?

Ans: The Applications covered in the Antiviral Drug Packaging Market report are Pharmaceuticals, Healthcare

What are the Type segmentation covered in the Antiviral Drug Packaging Market report?

Ans: The Types covered in the Antiviral Drug Packaging Market report are Rigid Plastic, Flexible Blister Foils, Others

1 Antiviral Drug Packaging Market Overview

1.1 Product Overview and Scope of Antiviral Drug Packaging

1.2 Antiviral Drug Packaging Segment by Type

1.2.1 Global Antiviral Drug Packaging Market Value Comparison by Type (2024-2030)

1.2.2 Rigid Plastic

1.2.3 Flexible Blister Foils

1.2.4 Others

1.3 Antiviral Drug Packaging Segment by Application

1.3.1 Global Antiviral Drug Packaging Market Value by Application: (2024-2030)

1.3.2 Pharmaceuticals

1.3.3 Healthcare

1.4 Global Antiviral Drug Packaging Market Size Estimates and Forecasts

1.4.1 Global Antiviral Drug Packaging Revenue 2019-2030

1.4.2 Global Antiviral Drug Packaging Sales 2019-2030

1.4.3 Global Antiviral Drug Packaging Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Antiviral Drug Packaging Market Competition by Manufacturers

2.1 Global Antiviral Drug Packaging Sales Market Share by Manufacturers (2019-2024)

2.2 Global Antiviral Drug Packaging Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Antiviral Drug Packaging Average Price by Manufacturers (2019-2024)

2.4 Global Antiviral Drug Packaging Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Antiviral Drug Packaging, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Antiviral Drug Packaging, Product Type & Application

2.7 Antiviral Drug Packaging Market Competitive Situation and Trends

2.7.1 Antiviral Drug Packaging Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Antiviral Drug Packaging Players Market Share by Revenue

2.7.3 Global Antiviral Drug Packaging Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Antiviral Drug Packaging Retrospective Market Scenario by Region

3.1 Global Antiviral Drug Packaging Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Antiviral Drug Packaging Global Antiviral Drug Packaging Sales by Region: 2019-2030

3.2.1 Global Antiviral Drug Packaging Sales by Region: 2019-2024

3.2.2 Global Antiviral Drug Packaging Sales by Region: 2025-2030

3.3 Global Antiviral Drug Packaging Global Antiviral Drug Packaging Revenue by Region: 2019-2030

3.3.1 Global Antiviral Drug Packaging Revenue by Region: 2019-2024

3.3.2 Global Antiviral Drug Packaging Revenue by Region: 2025-2030

3.4 North America Antiviral Drug Packaging Market Facts & Figures by Country

3.4.1 North America Antiviral Drug Packaging Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Antiviral Drug Packaging Sales by Country (2019-2030)

3.4.3 North America Antiviral Drug Packaging Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Antiviral Drug Packaging Market Facts & Figures by Country

3.5.1 Europe Antiviral Drug Packaging Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Antiviral Drug Packaging Sales by Country (2019-2030)

3.5.3 Europe Antiviral Drug Packaging Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Antiviral Drug Packaging Market Facts & Figures by Country

3.6.1 Asia Pacific Antiviral Drug Packaging Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Antiviral Drug Packaging Sales by Country (2019-2030)

3.6.3 Asia Pacific Antiviral Drug Packaging Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Antiviral Drug Packaging Market Facts & Figures by Country

3.7.1 Latin America Antiviral Drug Packaging Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Antiviral Drug Packaging Sales by Country (2019-2030)

3.7.3 Latin America Antiviral Drug Packaging Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Antiviral Drug Packaging Market Facts & Figures by Country

3.8.1 Middle East and Africa Antiviral Drug Packaging Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Antiviral Drug Packaging Sales by Country (2019-2030)

3.8.3 Middle East and Africa Antiviral Drug Packaging Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Antiviral Drug Packaging Sales by Type (2019-2030)

4.1.1 Global Antiviral Drug Packaging Sales by Type (2019-2024)

4.1.2 Global Antiviral Drug Packaging Sales by Type (2025-2030)

4.1.3 Global Antiviral Drug Packaging Sales Market Share by Type (2019-2030)

4.2 Global Antiviral Drug Packaging Revenue by Type (2019-2030)

4.2.1 Global Antiviral Drug Packaging Revenue by Type (2019-2024)

4.2.2 Global Antiviral Drug Packaging Revenue by Type (2025-2030)

4.2.3 Global Antiviral Drug Packaging Revenue Market Share by Type (2019-2030)

4.3 Global Antiviral Drug Packaging Price by Type (2019-2030)

5 Segment by Application

5.1 Global Antiviral Drug Packaging Sales by Application (2019-2030)

5.1.1 Global Antiviral Drug Packaging Sales by Application (2019-2024)

5.1.2 Global Antiviral Drug Packaging Sales by Application (2025-2030)

5.1.3 Global Antiviral Drug Packaging Sales Market Share by Application (2019-2030)

5.2 Global Antiviral Drug Packaging Revenue by Application (2019-2030)

5.2.1 Global Antiviral Drug Packaging Revenue by Application (2019-2024)

5.2.2 Global Antiviral Drug Packaging Revenue by Application (2025-2030)

5.2.3 Global Antiviral Drug Packaging Revenue Market Share by Application (2019-2030)

5.3 Global Antiviral Drug Packaging Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Avery Dennison Corporation

6.1.1 Avery Dennison Corporation Corporation Information

6.1.2 Avery Dennison Corporation Description and Business Overview

6.1.3 Avery Dennison Corporation Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Avery Dennison Corporation Antiviral Drug Packaging Product Portfolio

6.1.5 Avery Dennison Corporation Recent Developments/Updates

6.2 E.I. du Pont de Nemours

6.2.1 E.I. du Pont de Nemours Corporation Information

6.2.2 E.I. du Pont de Nemours Description and Business Overview

6.2.3 E.I. du Pont de Nemours Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

6.2.4 E.I. du Pont de Nemours Antiviral Drug Packaging Product Portfolio

6.2.5 E.I. du Pont de Nemours Recent Developments/Updates

6.3 CCL Industries Inc

6.3.1 CCL Industries Inc Corporation Information

6.3.2 CCL Industries Inc Description and Business Overview

6.3.3 CCL Industries Inc Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

6.3.4 CCL Industries Inc Antiviral Drug Packaging Product Portfolio

6.3.5 CCL Industries Inc Recent Developments/Updates

6.4 BioCote

6.4.1 BioCote Corporation Information

6.4.2 BioCote Description and Business Overview

6.4.3 BioCote Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

6.4.4 BioCote Antiviral Drug Packaging Product Portfolio

6.4.5 BioCote Recent Developments/Updates

6.5 Avient

6.5.1 Avient Corporation Information

6.5.2 Avient Description and Business Overview

6.5.3 Avient Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Avient Antiviral Drug Packaging Product Portfolio

6.5.5 Avient Recent Developments/Updates

6.6 Mondi

6.6.1 Mondi Corporation Information

6.6.2 Mondi Description and Business Overview

6.6.3 Mondi Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Mondi Antiviral Drug Packaging Product Portfolio

6.6.5 Mondi Recent Developments/Updates

6.7 Biomaster

6.6.1 Biomaster Corporation Information

6.6.2 Biomaster Description and Business Overview

6.6.3 Biomaster Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Biomaster Antiviral Drug Packaging Product Portfolio

6.7.5 Biomaster Recent Developments/Updates

6.8 BASF

6.8.1 BASF Corporation Information

6.8.2 BASF Description and Business Overview

6.8.3 BASF Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

6.8.4 BASF Antiviral Drug Packaging Product Portfolio

6.8.5 BASF Recent Developments/Updates

6.9 Lonza

6.9.1 Lonza Corporation Information

6.9.2 Lonza Description and Business Overview

6.9.3 Lonza Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Lonza Antiviral Drug Packaging Product Portfolio

6.9.5 Lonza Recent Developments/Updates

6.10 Takex Labo Co. Ltd

6.10.1 Takex Labo Co. Ltd Corporation Information

6.10.2 Takex Labo Co. Ltd Description and Business Overview

6.10.3 Takex Labo Co. Ltd Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Takex Labo Co. Ltd Antiviral Drug Packaging Product Portfolio

6.10.5 Takex Labo Co. Ltd Recent Developments/Updates

6.11 Berry

6.11.1 Berry Corporation Information

6.11.2 Berry Antiviral Drug Packaging Description and Business Overview

6.11.3 Berry Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Berry Antiviral Drug Packaging Product Portfolio

6.11.5 Berry Recent Developments/Updates

6.12 Lageen Tubes.

6.12.1 Lageen Tubes. Corporation Information

6.12.2 Lageen Tubes. Antiviral Drug Packaging Description and Business Overview

6.12.3 Lageen Tubes. Antiviral Drug Packaging Sales, Revenue and Gross Margin (2019-2024)

6.12.4 Lageen Tubes. Antiviral Drug Packaging Product Portfolio

6.12.5 Lageen Tubes. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Antiviral Drug Packaging Industry Chain Analysis

7.2 Antiviral Drug Packaging Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Antiviral Drug Packaging Production Mode & Process

7.4 Antiviral Drug Packaging Sales and Marketing

7.4.1 Antiviral Drug Packaging Sales Channels

7.4.2 Antiviral Drug Packaging Distributors

7.5 Antiviral Drug Packaging Customers

8 Antiviral Drug Packaging Market Dynamics

8.1 Antiviral Drug Packaging Industry Trends

8.2 Antiviral Drug Packaging Market Drivers

8.3 Antiviral Drug Packaging Market Challenges

8.4 Antiviral Drug Packaging Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Avery Dennison Corporation

E.I. du Pont de Nemours

List of Tables

Table 1. Global Antiviral Drug Packaging Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Antiviral Drug Packaging Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Antiviral Drug Packaging Market Competitive Situation by Manufacturers in 2023

Table 4. Global Antiviral Drug Packaging Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Antiviral Drug Packaging Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Antiviral Drug Packaging Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Antiviral Drug Packaging Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Antiviral Drug Packaging Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Antiviral Drug Packaging, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Antiviral Drug Packaging, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Antiviral Drug Packaging, Product Type & Application

Table 12. Global Key Manufacturers of Antiviral Drug Packaging, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Antiviral Drug Packaging by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Drug Packaging as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Antiviral Drug Packaging Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Antiviral Drug Packaging Sales by Region (2019-2024) & (K Units)

Table 18. Global Antiviral Drug Packaging Sales Market Share by Region (2019-2024)

Table 19. Global Antiviral Drug Packaging Sales by Region (2025-2030) & (K Units)

Table 20. Global Antiviral Drug Packaging Sales Market Share by Region (2025-2030)

Table 21. Global Antiviral Drug Packaging Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Antiviral Drug Packaging Revenue Market Share by Region (2019-2024)

Table 23. Global Antiviral Drug Packaging Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Antiviral Drug Packaging Revenue Market Share by Region (2025-2030)

Table 25. North America Antiviral Drug Packaging Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Antiviral Drug Packaging Sales by Country (2019-2024) & (K Units)

Table 27. North America Antiviral Drug Packaging Sales by Country (2025-2030) & (K Units)

Table 28. North America Antiviral Drug Packaging Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Antiviral Drug Packaging Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Antiviral Drug Packaging Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Antiviral Drug Packaging Sales by Country (2019-2024) & (K Units)

Table 32. Europe Antiviral Drug Packaging Sales by Country (2025-2030) & (K Units)

Table 33. Europe Antiviral Drug Packaging Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Antiviral Drug Packaging Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Antiviral Drug Packaging Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Antiviral Drug Packaging Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Antiviral Drug Packaging Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Antiviral Drug Packaging Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Antiviral Drug Packaging Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Antiviral Drug Packaging Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Antiviral Drug Packaging Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Antiviral Drug Packaging Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Antiviral Drug Packaging Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Antiviral Drug Packaging Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Antiviral Drug Packaging Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Antiviral Drug Packaging Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Antiviral Drug Packaging Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Antiviral Drug Packaging Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Antiviral Drug Packaging Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Antiviral Drug Packaging Sales (K Units) by Type (2019-2024)

Table 51. Global Antiviral Drug Packaging Sales (K Units) by Type (2025-2030)

Table 52. Global Antiviral Drug Packaging Sales Market Share by Type (2019-2024)

Table 53. Global Antiviral Drug Packaging Sales Market Share by Type (2025-2030)

Table 54. Global Antiviral Drug Packaging Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Antiviral Drug Packaging Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Antiviral Drug Packaging Revenue Market Share by Type (2019-2024)

Table 57. Global Antiviral Drug Packaging Revenue Market Share by Type (2025-2030)

Table 58. Global Antiviral Drug Packaging Price (US$/Unit) by Type (2019-2024)

Table 59. Global Antiviral Drug Packaging Price (US$/Unit) by Type (2025-2030)

Table 60. Global Antiviral Drug Packaging Sales (K Units) by Application (2019-2024)

Table 61. Global Antiviral Drug Packaging Sales (K Units) by Application (2025-2030)

Table 62. Global Antiviral Drug Packaging Sales Market Share by Application (2019-2024)

Table 63. Global Antiviral Drug Packaging Sales Market Share by Application (2025-2030)

Table 64. Global Antiviral Drug Packaging Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Antiviral Drug Packaging Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Antiviral Drug Packaging Revenue Market Share by Application (2019-2024)

Table 67. Global Antiviral Drug Packaging Revenue Market Share by Application (2025-2030)

Table 68. Global Antiviral Drug Packaging Price (US$/Unit) by Application (2019-2024)

Table 69. Global Antiviral Drug Packaging Price (US$/Unit) by Application (2025-2030)

Table 70. Avery Dennison Corporation Corporation Information

Table 71. Avery Dennison Corporation Description and Business Overview

Table 72. Avery Dennison Corporation Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Avery Dennison Corporation Antiviral Drug Packaging Product

Table 74. Avery Dennison Corporation Recent Developments/Updates

Table 75. E.I. du Pont de Nemours Corporation Information

Table 76. E.I. du Pont de Nemours Description and Business Overview

Table 77. E.I. du Pont de Nemours Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. E.I. du Pont de Nemours Antiviral Drug Packaging Product

Table 79. E.I. du Pont de Nemours Recent Developments/Updates

Table 80. CCL Industries Inc Corporation Information

Table 81. CCL Industries Inc Description and Business Overview

Table 82. CCL Industries Inc Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. CCL Industries Inc Antiviral Drug Packaging Product

Table 84. CCL Industries Inc Recent Developments/Updates

Table 85. BioCote Corporation Information

Table 86. BioCote Description and Business Overview

Table 87. BioCote Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. BioCote Antiviral Drug Packaging Product

Table 89. BioCote Recent Developments/Updates

Table 90. Avient Corporation Information

Table 91. Avient Description and Business Overview

Table 92. Avient Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Avient Antiviral Drug Packaging Product

Table 94. Avient Recent Developments/Updates

Table 95. Mondi Corporation Information

Table 96. Mondi Description and Business Overview

Table 97. Mondi Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Mondi Antiviral Drug Packaging Product

Table 99. Mondi Recent Developments/Updates

Table 100. Biomaster Corporation Information

Table 101. Biomaster Description and Business Overview

Table 102. Biomaster Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Biomaster Antiviral Drug Packaging Product

Table 104. Biomaster Recent Developments/Updates

Table 105. BASF Corporation Information

Table 106. BASF Description and Business Overview

Table 107. BASF Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. BASF Antiviral Drug Packaging Product

Table 109. BASF Recent Developments/Updates

Table 110. Lonza Corporation Information

Table 111. Lonza Description and Business Overview

Table 112. Lonza Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Lonza Antiviral Drug Packaging Product

Table 114. Lonza Recent Developments/Updates

Table 115. Takex Labo Co. Ltd Corporation Information

Table 116. Takex Labo Co. Ltd Description and Business Overview

Table 117. Takex Labo Co. Ltd Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Takex Labo Co. Ltd Antiviral Drug Packaging Product

Table 119. Takex Labo Co. Ltd Recent Developments/Updates

Table 120. Berry Corporation Information

Table 121. Berry Description and Business Overview

Table 122. Berry Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Berry Antiviral Drug Packaging Product

Table 124. Berry Recent Developments/Updates

Table 125. Lageen Tubes. Corporation Information

Table 126. Lageen Tubes. Description and Business Overview

Table 127. Lageen Tubes. Antiviral Drug Packaging Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. Lageen Tubes. Antiviral Drug Packaging Product

Table 129. Lageen Tubes. Recent Developments/Updates

Table 130. Key Raw Materials Lists

Table 131. Raw Materials Key Suppliers Lists

Table 132. Antiviral Drug Packaging Distributors List

Table 133. Antiviral Drug Packaging Customers List

Table 134. Antiviral Drug Packaging Market Trends

Table 135. Antiviral Drug Packaging Market Drivers

Table 136. Antiviral Drug Packaging Market Challenges

Table 137. Antiviral Drug Packaging Market Restraints

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Antiviral Drug Packaging

Figure 2. Global Antiviral Drug Packaging Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Antiviral Drug Packaging Market Share by Type in 2023 & 2030

Figure 4. Rigid Plastic Product Picture

Figure 5. Flexible Blister Foils Product Picture

Figure 6. Others Product Picture

Figure 7. Global Antiviral Drug Packaging Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Antiviral Drug Packaging Market Share by Application in 2023 & 2030

Figure 9. Pharmaceuticals

Figure 10. Healthcare

Figure 11. Global Antiviral Drug Packaging Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 12. Global Antiviral Drug Packaging Market Size (2019-2030) & (US$ Million)

Figure 13. Global Antiviral Drug Packaging Sales (2019-2030) & (K Units)

Figure 14. Global Antiviral Drug Packaging Average Price (US$/Unit) & (2019-2030)

Figure 15. Antiviral Drug Packaging Report Years Considered

Figure 16. Antiviral Drug Packaging Sales Share by Manufacturers in 2023

Figure 17. Global Antiviral Drug Packaging Revenue Share by Manufacturers in 2023

Figure 18. The Global 5 and 10 Largest Antiviral Drug Packaging Players: Market Share by Revenue in 2023

Figure 19. Antiviral Drug Packaging Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 20. Global Antiviral Drug Packaging Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 21. North America Antiviral Drug Packaging Sales Market Share by Country (2019-2030)

Figure 22. North America Antiviral Drug Packaging Revenue Market Share by Country (2019-2030)

Figure 23. United States Antiviral Drug Packaging Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Canada Antiviral Drug Packaging Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Europe Antiviral Drug Packaging Sales Market Share by Country (2019-2030)

Figure 26. Europe Antiviral Drug Packaging Revenue Market Share by Country (2019-2030)

Figure 27. Germany Antiviral Drug Packaging Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. France Antiviral Drug Packaging Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. U.K. Antiviral Drug Packaging Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Italy Antiviral Drug Packaging Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Russia Antiviral Drug Packaging Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Antiviral Drug Packaging Sales Market Share by Region (2019-2030)

Figure 33. Asia Pacific Antiviral Drug Packaging Revenue Market Share by Region (2019-2030)

Figure 34. China Antiviral Drug Packaging Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Japan Antiviral Drug Packaging Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. South Korea Antiviral Drug Packaging Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. India Antiviral Drug Packaging Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Australia Antiviral Drug Packaging Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. China Taiwan Antiviral Drug Packaging Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Southeast Asia Antiviral Drug Packaging Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Latin America Antiviral Drug Packaging Sales Market Share by Country (2019-2030)

Figure 42. Latin America Antiviral Drug Packaging Revenue Market Share by Country (2019-2030)

Figure 43. Mexico Antiviral Drug Packaging Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Brazil Antiviral Drug Packaging Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Argentina Antiviral Drug Packaging Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Antiviral Drug Packaging Sales Market Share by Country (2019-2030)

Figure 47. Middle East & Africa Antiviral Drug Packaging Revenue Market Share by Country (2019-2030)

Figure 48. Turkey Antiviral Drug Packaging Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Saudi Arabia Antiviral Drug Packaging Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. UAE Antiviral Drug Packaging Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 51. Global Sales Market Share of Antiviral Drug Packaging by Type (2019-2030)

Figure 52. Global Revenue Market Share of Antiviral Drug Packaging by Type (2019-2030)

Figure 53. Global Antiviral Drug Packaging Price (US$/Unit) by Type (2019-2030)

Figure 54. Global Sales Market Share of Antiviral Drug Packaging by Application (2019-2030)

Figure 55. Global Revenue Market Share of Antiviral Drug Packaging by Application (2019-2030)

Figure 56. Global Antiviral Drug Packaging Price (US$/Unit) by Application (2019-2030)

Figure 57. Antiviral Drug Packaging Value Chain

Figure 58. Antiviral Drug Packaging Production Process

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Distributors Profiles

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions